Rapid Novor will be exhibiting at the Antibody Engineering & Therapeutics Asia conference in Kyoto, Japan at the Westin Miyako Kyoto hotel.
Stop by Booth #6 to find out why over 240 research institutions have incorporated REmAb® into their pipeline.

Interested in attending? Contact us to receive a FREE hall pass!

Anthony will be in Japan from February 24-March 6. Please contact Anthony if you are interested in setting up a face-to-face meeting.

Anthony Stajduhar - Business Development Manager+1 (519) 593-2667 | anthony@rapidnovor.com

Newsletter for All Things Protein Sequencing

Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.

Talk to Our Scientists.

We Have Sequenced 6000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 6000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 6000 antibodies and we are eager to help you.